Almirall and Forest Laboratories Announce Positive Phase III Study Results for Aclidinium and Formoterol Combination in COPD

[at noodls] – Aclidinium / Formoterol Fixed Dose Combinations Twice Daily Show Statistically Significant Improvements in the Two Co-Primary Endpoints in the First Pivotal COPD Study a Second Pivotal Phase III Study … more

View todays social media effects on FRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Forest is hiring next, click here to view